Antibe Therapeutics Inc. announced the hiring of Dr. Rami Batal in the new role of Senior VP, Commercial Strategy. The creation of this position represents a further step in the Company's partnering efforts for its lead drug, ATB-346, and for its overall drug platform. Rami's role will be to leverage the Company's recent commercial strategy initiatives, including the now-completed health economics study, and the on-going comprehensive market opportunity assessment and payor study. A key aspect of his role involves providing partners with a robust commercial strategy package, including an in-depth framework on positioning, launch-planning and reimbursement. The Company also announced that Scott Curtis has been promoted to the newly created position of Executive VP to coordinate corporate activities as business development activities accelerate.